Daniel Kraft, MD’s Post

Do you know how smoke-free products are evolving? What is the impact these products are having on public health? These questions will be answered by my colleagues Carrie Wade, Christelle Haziza, and Thomas McGrath on June 12 at the Open Science event about the INNOVATION and SCIENCE behind smoke-free products. WHEN: June 12 at 5:00 p.m. CEST HOW: CLICK ATTEND here ➡️ https://lnkd.in/eegs93z2 to not miss this opportunity. JOIN in on the discussion by asking YOUR QUESTIONS in the event chat. #OpenScience #PublicHealth #ScienceInnovation #ScienceProgress #ScientificEvidence

Do you know how smoke-free products are evolving? What is the impact these products are having on public health? These questions will be answered by my colleagues Carrie Wade, Christelle Haziza, and Thomas McGrath on June 12 at the Open Science event about the INNOVATION and SCIENCE behind smoke-free products. WHEN: June 12 at 5:00 p.m. CEST HOW: CLICK ATTEND here ➡️ https://lnkd.in/eQp3aM49 to not miss this opportunity. JOIN in on the discussion by asking YOUR QUESTIONS in the event chat. #OpenScience #PublicHealth #ScienceInnovation #ScienceProgress #ScientificEvidence

Do you know how smoke-free products are evolving? What is the impact these products are having on public health? These questions will be answered by my colleagues Carrie Wade, Christelle Haziza, and Thomas McGrath on June 12 at the Open Science event about the INNOVATION and SCIENCE behind smoke-free products. WHEN: June 12 at 5:00 p.m. CEST HOW: CLICK ATTEND here ➡️ https://lnkd.in/eNm9FXbX to not miss this opportunity. JOIN in on the discussion by asking YOUR QUESTIONS in the event chat. #OpenScience #PublicHealth #ScienceInnovation #ScienceProgress #ScientificEvidence

Increasing diversity in clinical trials and all research is vital in understanding how health interventions can affect patients differently. Altura CEO Pete Fronte, MBA chaired a forum on this topic at the DIA 2024 Global Annual Meeting in June. Dr. Karen Correa, PhD,BCMAS, Takeda; Dr. Jim Schultz, Neighborhood Healthcare; and clinical trial patient Mario DuCre discussed how community health centers (CHCs) and life science companies can play a key role in boosting clinical study involvement among underrepresented populations. View the presentation: #diversity #healthequity #clinicalresearch #chcs #lifesciences

💡 Thrilled to share this article co-authored by Leah Carlisle and me! Behavioral science has gained significant traction in healthcare, and for good reason. The notion that insufficient knowledge or awareness is the sole driver of healthcare issues has been debunked. From vaccine hesitancy to treatment adherence and various other common issues, these are behavioral challenges, and addressing them requires uncovering the underlying decision drivers and barriers of human behavior. Leah and I have distilled our recent conference experiences into five key learnings, empowering you to strengthen connections across the patient journey. ❗ Spoiler alert: Behavior change interactions ultimately contribute to advancing healthcare and improving patient outcomes! Check out our latest article and reach out to learn more about how we at Avalere Health can assist you in applying a behavioral science lens throughout the product lifecycle and inspiring effective change while keeping the patient at the heart of what you do. #BehavioralScience #HealthcareInsights #AvalereHealth Read the full article here: https://lnkd.in/dWwsFRTv

Five key takeaways from the Future of Health Summit in Austin put on by Health Tech Austin

We are thrilled to be in NJ to present to the membership of Innovation Roundtable, a World 50 Group Community EHIR, a coalition of the country's largest and most progressive employers focused on accelerating the adoption of innovation to improve employee health and productivity. We'll be talking to the employers in Cohort 5 (https://lnkd.in/gKZVTmPz). We are thrilled to showcase our powerful solution helping battle the autoimmune epidemic -- an epidemic that’s quietly and quickly crippling the workforce: - 1 in 5 Americans suffers from an autoimmune disease -- 80% are women. - 78% of full-time employees say their work has been affected by their autoimmune disease - 63% cannot work full time - 50% of employees with Rheumatoid Arthritis (an autoimmune condition) leave the workforce less than 10 years after disease onset - Spending on autoimmune medications increased 459% over the last decade This opportunity marks another major stride in illuminating the impact of autoimmune disease and creating the change we need to see. To learn more about WellTheory, visit us at https://lnkd.in/geaeYf5p.

Do you work in Life Sciences? I am thrilled to share that I have been invited to speak at this autumn's Westminster Health Forum policy conference on Priorities for Life Sciences. The conference is scheduled to take place online on October 31st, 2023. This event will bring together experts, policymakers, industry representatives, and stakeholders to discuss the future ambitions for the delivery of the Life Sciences Vision and the priorities and challenges for the new Tackling Health Challenges Taskforce. We'll be diving into crucial topics such as supporting the life sciences industry, regulatory changes, innovation, patient access to innovation, and much more. I am particularly excited to contribute to the panel discussion titled "The Vaccine Taskforce model approach to tackling obesity, cancer, mental health, and addiction," which aims to cut bureaucracy, build strong cross-industry partnerships, and lead global research. As we navigate the evolving landscape of healthcare and life sciences, your insights and expertise are essential. Join me and other leaders in these important conversations. Westminster Forum Projects #LifeSciences #Healthcare #Innovation #PolicyConference #ExpertPanel #Collaboration #FutureOfHealthcare

We all have a reason. Whether it is for our family, community, future generations, or ourself, participating in health research improves the lives of all those around us.💙 #allofuswisconsin Have you felt a calling to improve the lives of others - to impact healthcare in Wisconsin? This is your time. Click Learn More to Feel The Power of One or 👇 Join today to become one in a million: https://lnkd.in/dPf3ngYs What is the All of Us Research Program? First off, did you know you don't need to be physically present to enroll? Check out the top 10 FAQ's: https://lnkd.in/d7t9gUWw "The All of Us Research Program is a historic, longitudinal effort to gather data from one million or more people living in the United States to accelerate research and improve health. By taking into account individual differences in lifestyle, socioeconomics, environment, and biology, we hope that researchers will one day uncover paths toward delivering precision medicine – or individualized prevention, treatment, and care – for all of us." Marshfield Clinic Health System Feel free to connect me on lewis.adarsh@marshfieldresearch.org to know more. Let's partner!

#LongCovidAwarenessDay is coming up! As part of our commitment to advancing Long Covid research, we've launched a Long Covid treatment survey to gather data through CURE ID. Our goal is to collect 1,000 cases by March 15th, providing valuable insights into the diverse treatments of Long Covid in order to guide future research and treatment strategies. How You Can Help: • Submit your Cases: If you're a healthcare professional or a Long Covid sufferer, we encourage you to report cases on CURE ID. Your contribution will play a crucial role in expanding our understanding of Long Covid and accelerating the search for effective treatment options. • Spread Awareness: Share this message and raise awareness about Long Covid and the importance of participation through CURE ID. Together, we can amplify our impact and make a meaningful difference in the lives of Long Covid patients. By coming together as a community, we can drive progress in Long COVID research and support those affected by this challenging condition. Let's unite our efforts and work towards a future where effective treatments are available for all. Join us in our mission to collet 1,000 cases on CURE ID by March 15th!   If you need assistance in filling out the survey, you can contact curesupport@nih.gov to get assistance on entering your case. Please take the time and energy to do this small but important piece of advocacy that can move treatments forward in a meaningful way! National Center for Advancing Translational Sciences (NCATS)| Heather Stone| Critical Path Institute (C-Path)| Dysautonomia International| Patient-Led Research Collaborative| Solve ME/CFS Initiative| #MEAction| Lisa Schill #LongCOVIDAwarenessDay #CUREID #LongCOVIDResearch